Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives

Loïc Guillevin, Iain Armstrong, Rino Aldrighetti, Luke S. Howard, Henrik Ryftenius, Aryeh Fischer, Sandra Lombardi, Sean Studer, Pisana Ferrari
European Respiratory Review 2013 22: 535-542; DOI: 10.1183/09059180.00005713
Loïc Guillevin
1Service de Médecine Interne, Hôpital Cochin, Paris, France. 2Pulmonary Hypertension Association UK, Rotherham, and 4National Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College London, London, UK. 3Pulmonary Hypertension Association US, Silver Spring, MD, 6Division of Rheumatology, Dept of Medicine, National Jewish Health, Denver, CO, 7UCSD Medical Center, San Diego, CA, and 8Woodhull Medical Center, New York University, New York, NY, USA. 5Lung Allergy Clinic, Karolinska University Hospital, Stockholm, Sweden. 9Pulmonary Hypertension Association Europe, Vienna, Austria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: loic.guillevin@cch.ap-hop-paris.fr
Iain Armstrong
1Service de Médecine Interne, Hôpital Cochin, Paris, France. 2Pulmonary Hypertension Association UK, Rotherham, and 4National Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College London, London, UK. 3Pulmonary Hypertension Association US, Silver Spring, MD, 6Division of Rheumatology, Dept of Medicine, National Jewish Health, Denver, CO, 7UCSD Medical Center, San Diego, CA, and 8Woodhull Medical Center, New York University, New York, NY, USA. 5Lung Allergy Clinic, Karolinska University Hospital, Stockholm, Sweden. 9Pulmonary Hypertension Association Europe, Vienna, Austria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rino Aldrighetti
1Service de Médecine Interne, Hôpital Cochin, Paris, France. 2Pulmonary Hypertension Association UK, Rotherham, and 4National Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College London, London, UK. 3Pulmonary Hypertension Association US, Silver Spring, MD, 6Division of Rheumatology, Dept of Medicine, National Jewish Health, Denver, CO, 7UCSD Medical Center, San Diego, CA, and 8Woodhull Medical Center, New York University, New York, NY, USA. 5Lung Allergy Clinic, Karolinska University Hospital, Stockholm, Sweden. 9Pulmonary Hypertension Association Europe, Vienna, Austria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luke S. Howard
1Service de Médecine Interne, Hôpital Cochin, Paris, France. 2Pulmonary Hypertension Association UK, Rotherham, and 4National Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College London, London, UK. 3Pulmonary Hypertension Association US, Silver Spring, MD, 6Division of Rheumatology, Dept of Medicine, National Jewish Health, Denver, CO, 7UCSD Medical Center, San Diego, CA, and 8Woodhull Medical Center, New York University, New York, NY, USA. 5Lung Allergy Clinic, Karolinska University Hospital, Stockholm, Sweden. 9Pulmonary Hypertension Association Europe, Vienna, Austria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henrik Ryftenius
1Service de Médecine Interne, Hôpital Cochin, Paris, France. 2Pulmonary Hypertension Association UK, Rotherham, and 4National Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College London, London, UK. 3Pulmonary Hypertension Association US, Silver Spring, MD, 6Division of Rheumatology, Dept of Medicine, National Jewish Health, Denver, CO, 7UCSD Medical Center, San Diego, CA, and 8Woodhull Medical Center, New York University, New York, NY, USA. 5Lung Allergy Clinic, Karolinska University Hospital, Stockholm, Sweden. 9Pulmonary Hypertension Association Europe, Vienna, Austria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aryeh Fischer
1Service de Médecine Interne, Hôpital Cochin, Paris, France. 2Pulmonary Hypertension Association UK, Rotherham, and 4National Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College London, London, UK. 3Pulmonary Hypertension Association US, Silver Spring, MD, 6Division of Rheumatology, Dept of Medicine, National Jewish Health, Denver, CO, 7UCSD Medical Center, San Diego, CA, and 8Woodhull Medical Center, New York University, New York, NY, USA. 5Lung Allergy Clinic, Karolinska University Hospital, Stockholm, Sweden. 9Pulmonary Hypertension Association Europe, Vienna, Austria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Lombardi
1Service de Médecine Interne, Hôpital Cochin, Paris, France. 2Pulmonary Hypertension Association UK, Rotherham, and 4National Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College London, London, UK. 3Pulmonary Hypertension Association US, Silver Spring, MD, 6Division of Rheumatology, Dept of Medicine, National Jewish Health, Denver, CO, 7UCSD Medical Center, San Diego, CA, and 8Woodhull Medical Center, New York University, New York, NY, USA. 5Lung Allergy Clinic, Karolinska University Hospital, Stockholm, Sweden. 9Pulmonary Hypertension Association Europe, Vienna, Austria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sean Studer
1Service de Médecine Interne, Hôpital Cochin, Paris, France. 2Pulmonary Hypertension Association UK, Rotherham, and 4National Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College London, London, UK. 3Pulmonary Hypertension Association US, Silver Spring, MD, 6Division of Rheumatology, Dept of Medicine, National Jewish Health, Denver, CO, 7UCSD Medical Center, San Diego, CA, and 8Woodhull Medical Center, New York University, New York, NY, USA. 5Lung Allergy Clinic, Karolinska University Hospital, Stockholm, Sweden. 9Pulmonary Hypertension Association Europe, Vienna, Austria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pisana Ferrari
1Service de Médecine Interne, Hôpital Cochin, Paris, France. 2Pulmonary Hypertension Association UK, Rotherham, and 4National Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College London, London, UK. 3Pulmonary Hypertension Association US, Silver Spring, MD, 6Division of Rheumatology, Dept of Medicine, National Jewish Health, Denver, CO, 7UCSD Medical Center, San Diego, CA, and 8Woodhull Medical Center, New York University, New York, NY, USA. 5Lung Allergy Clinic, Karolinska University Hospital, Stockholm, Sweden. 9Pulmonary Hypertension Association Europe, Vienna, Austria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Impact of pulmonary arterial hypertension on work and employment for patients and carers. #: participants were not asked for net or gross income so results assumed to be after tax.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Frequency of emotions experienced by a) pulmonary arterial hypertension (PAH) patients and b) their carers.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    The main information needs for 317 patients with pulmonary arterial hypertension (PAH).

Tables

  • Figures
  • Additional Files
  • Table 1. Demographic characteristics of the respondents
    PatientsCarers
    Subjects n326129
    Mean age years5252
    Females %7456
    Country
        France70 (21)29 (22)
        Germany97 (30)11 (9)
        Italy81 (25)50 (39)
        Spain45 (14)31 (24)
        UK33 (10)8 (6)
    Type of PAH
        Idiopathic PAH160 (49)70 (54)
        Family history of PAH16 (5)5 (4)
        PAH associated with CTD42 (13)13 (10)
        PAH associated with CHD39 (12)18 (14)
        PAH associated with HIV7 (2)
        PAH associated with another disease42 (13)15 (12)
        Not sure20 (6)8 (6)
    WHO/NYHA functional class
        I16 (5)4 (3)
        II163 (50)40 (31)
        III111 (34)55 (43)
        IV36 (11)30 (23)
    • Data are presented as n (%), unless otherwise stated. PAH: pulmonary arterial hypertension; CTD: connective tissue disease; CHD: congenital heart disease; WHO: World Health Organization; NYHA: New York Heart Association.

Additional Files

  • Figures
  • Tables
  • Supplementary material

    Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.

    Files in this Data Supplement:

    • Supplementary material -
      Patient questionnaire
      Carer questionnaire
  • Disclosures

    Files in this Data Supplement:

    • R. Aldrighetti
    • I. Armstrong
    • P. Ferrari
    • A. Fischer
    • L. Guillevin
    • L.S. Howard
    • S. Lombardi
    • H. Ryftenius
    • S. Studer
PreviousNext
Back to top
View this article with LENS
Vol 22 Issue 130 Table of Contents
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives
Loïc Guillevin, Iain Armstrong, Rino Aldrighetti, Luke S. Howard, Henrik Ryftenius, Aryeh Fischer, Sandra Lombardi, Sean Studer, Pisana Ferrari
European Respiratory Review Dec 2013, 22 (130) 535-542; DOI: 10.1183/09059180.00005713

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives
Loïc Guillevin, Iain Armstrong, Rino Aldrighetti, Luke S. Howard, Henrik Ryftenius, Aryeh Fischer, Sandra Lombardi, Sean Studer, Pisana Ferrari
European Respiratory Review Dec 2013, 22 (130) 535-542; DOI: 10.1183/09059180.00005713
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Introduction
    • Key findings from the international survey
    • Implications for the future management of PAH
    • Conclusion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary pharmacology and therapeutics
  • Pulmonary vascular disease
  • Respiratory clinical practice
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Role of air pollutants in airway epithelial barrier dysfunction
  • E-cigarettes and nicotine abstinence
  • Lung imaging in cystic fibrosis
Show more Review

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2023 by the European Respiratory Society